Abstract:Loss of epidermal growth factor receptor (EGFR) activity in mice alters growth plate development, impairs endochondral ossification, and retards growth. However, the detailed mechanism by which EGFR regulates endochondral bone formation is unknown. Here, we show that administration of an EGFR-specific small-molecule inhibitor, gefitinib, into 1-month-old rats for 7 days produced profound defects in long bone growth plate cartilage characterized by epiphyseal growth plate thickening and massive accumulation of hypertrophic chondrocytes. Immunostaining demonstrated that growth plate chondrocytes express EGFR, but endothelial cells and osteoclasts show little to no expression. Gefitinib did not alter chondrocyte proliferation or differentiation and vascular invasion into the hypertrophic cartilage. However, osteoclast recruitment and differentiation at the chondro-osseous junction were attenuated owing to decreased RANKL expression in the growth plate. Moreover, gefitinib treatment inhibited the expression of matrix metalloproteinases (MMP-9, -13, and -14), increased the amount of collagen fibrils, and decreased degraded extracellular matrix products in the growth plate. In vitro, the EGFR ligand transforming growth factor alpha (TGF-alpha) strongly stimulated RANKL and MMPs expression and suppressed osteoprotegerin (OPG) expression in primary chondrocytes. In addition, a mouse model of cartilage-specific EGFR inactivation exhibited a similar phenotype of hypertrophic cartilage enlargement. Together our data demonstrate that EGFR signaling supports osteoclastogenesis at the chondro-osseous junction and promotes chondrogenic expression of MMPs in the growth plate. Therefore, we conclude that EGFR signaling plays an essential role in the remodeling of growth plate cartilage extracellular matrix into bone during endochondral ossification. (C) 2011 American Society for Bone and Mineral Research.

Corin is a Key Regulator of Endochondral Ossification and Bone Development Via Modulation of Vascular Endothelial Growth Factor A Expression.

Corilagin Suppresses RANKL‐induced Osteoclastogenesis and Inhibits Oestrogen Deficiency‐induced Bone Loss Via the NF‐κB and PI3K/AKT Signalling Pathways

Deficiencies in Corin and Atrial Natriuretic Peptide-Mediated Signaling Impair Endochondral Ossification in Bone Development

Corin deficiency impairs cardiac function in mouse models of heart failure

Role of the Protease Corin in Chondrogenic Differentiation of Human Bone Marrow‐derived Mesenchymal Stem Cells

Corin is highly expressed in atherosclerosis models.

Reduced serum corin levels in patients with osteoporosis.

Systematic Transcriptome Profiling of Hpsc-Derived Osteoblasts Unveils CORIN's Mastery in Governing Osteogenesis Through CEBPD Modulation

Corin in Clinical Laboratory Diagnostics

Protease corin expression and activity in failing hearts.

Corin Deficiency Alters Adipose Tissue Phenotype and Impairs Thermogenesis in Mice.

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

Corin Variant Associated With Hypertension And Cardiac Hypertrophy Exhibits Impaired Zymogen Activation And Natriuretic Peptide Processing Activity

Distinct VEGF functions during bone development and homeostasis

Function and Regulation of Corin in Physiology and Disease.

The Critical Role of the Epidermal Growth Factor Receptor in Endochondral Ossification

Corin: A Key Mediator in Sodium Homeostasis, Vascular Remodeling, and Heart Failure

Novel Function of Osteocalcin in Chondrocyte Differentiation and Endochondral Ossification Revealed on a CRISPR/Cas9 bglap–bglap2 Deficiency Mouse Model

Upregulation of Corin Gene Expression in Hypertrophic Cardiomyocytes and Failing Myocardium

Recombinant Soluble Corin Improves Cardiac Function in Mouse Models of Heart Failure